Publications by the researcher in collaboration with María Asunción García Sánchez (35)

2023

  1. Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”

    Respiratory Medicine

  2. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  3. Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2

2022

  1. Effects of Therapeutic Antibodies on Gene and Protein Signatures in Asthma Patients: A Comparative Systematic Review

    Biomedicines, Vol. 10, Núm. 2

  2. Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease

    Genes, Vol. 13, Núm. 4

2021

  1. Genetics and Epigenetics of Nasal Polyposis: A Systematic Review

    Journal of investigational allergology & clinical immunology, Vol. 31, Núm. 3, pp. 196-211

  2. PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 9

  3. Increased TPSAB1 Copy Number in a Family With Elevated Basal Serum Levels of Tryptase

    Frontiers in Medicine, Vol. 8

  4. IL-5 Receptor Subunit Alpha Expression As A Possible Biomarker In Asthma

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 2, pp. AB245

2020

  1. Genetics and epigenetics of atopic dermatitis: An updated systematic review

    Genes, Vol. 11, Núm. 4

  2. Atopy can be an interfering factor in genetic association studies of ß-lactam allergy

    Journal of Investigational Allergology and Clinical Immunology

  3. Promoter genotyping and mRNA expression– based analysis of the PTGDR gene in allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 2, pp. 117-126

  4. Molecular Analysis of IL-5 Receptor Subunit Alpha as a Possible Pharmacogenetic Biomarker in Asthma

    Frontiers in Medicine, Vol. 7

2019

  1. YRNAs overexpression and potential implications in allergy

    World Allergy Organization Journal, Vol. 12, Núm. 8

  2. PTGDR expression is upregulated through retinoic acid receptors (RAR) mechanism in allergy

    PLoS ONE, Vol. 14, Núm. 4

2018

  1. Cluster Analysis Identifies 3 Phenotypes within Allergic Asthma

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 6, Núm. 3, pp. 955-961.e1

2017

  1. Pharmacogenetics and the treatment of asthma

    Pharmacogenomics, Vol. 18, Núm. 13, pp. 1271-1280

  2. PTGDR gene expression and response to dexamethasone treatment in an in vitro model

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Retinoic acid modulates PTGDR promoter activity

    Journal of Investigational Allergology and Clinical Immunology, Vol. 26, Núm. 4, pp. 249-255

  2. Analysis of FOXP3 gene in children with allergy and autoimmune diseases

    Allergologia et Immunopathologia, Vol. 44, Núm. 1, pp. 32-40